Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
azithromycin stada filmuhúðuð tafla 500 mg
stada arzneimittel ag - azithromycinum mónóhýdrat - filmuhúðuð tafla - 500 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
azithromycin stada mixtúruduft, dreifa 40 mg/ml
stada arzneimittel ag - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
zitromax filmuhúðuð tafla 500 mg
pfizer aps - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
zitromax mixtúruduft, dreifa 40 mg/ml
pfizer aps - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
zitromax stofn fyrir innrennslisþykkni, lausn 500 mg
pfizer aps - azithromycinum díhýdrat - stofn fyrir innrennslisþykkni, lausn - 500 mg
Evrópusambandið -
íslenska -
EMA (European Medicines Agency)
suliqua
sanofi winthrop industrie - insúlín glargine, lixisenatide - sykursýki, tegund 2 - lyf notuð við sykursýki - suliqua is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus to improve glycaemic control as an adjunct to diet and exercise in addition to metformin with or without sglt-2 inhibitors.
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
panodil zapp filmuhúðuð tafla 500 mg
haleon denmark aps - paracetamolum inn - filmuhúðuð tafla - 500 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
panodil junior mixtúra, dreifa 24 mg/ml
haleon denmark aps - paracetamolum inn - mixtúra, dreifa - 24 mg/ml
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
panodil junior endaþarmsstíll 125 mg
haleon denmark aps - paracetamolum inn - endaþarmsstíll - 125 mg
Ísland -
íslenska -
LYFJASTOFNUN (Icelandic Medicines Agency)
panodil hot mixtúruduft, lausn 500 mg
haleon denmark aps - paracetamolum inn - mixtúruduft, lausn - 500 mg